Careers  |  Sign In  |  Register  |   Twitter

Latest in Orthopedics

Reuters reports that "two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe." The product, known as Infuse, was "once hailed as a major advance in spine surgery by offering a...
The Associated Press reports that the Food and Drug Administration approved a new use for Xgeva, a bone drug made by Amgen. The medication, which had previously been approved for "preventing skeletal damage from solid tumors," is now okayed to treat "a rare condition, giant cell tumor of bone, when surgery...
In a new study published in Molecular Therapy, researchers reported the "first example of the restoration of protein expression from an endogenous mutated gene through template-free NHEJ [non-homologous end joining]-mediated DNA repair." In other words, researchers used transcription activator-like...